The Microbiome Movement – Drug Development Summit
Craig Thomson will be hosting a Microbiome IP Masterclass at the 3rd Annual Microbiome Drug Development Summit in Boston, June 2018.
Now in its 3rd year, The Microbiome Movement – Drug Development Summit continues to be the industry leading forum that focuses exclusively on the development and commercialisation of microbiome-based therapeutics; with case-studies from target discovery all the way through to clinical trial development, manufacturing and beyond.
Partner, Craig Thomson will be hosting a Microbiome Intellectual Property Masterclass: Developing an IP strategy for Attracting Investment workshop on Conference Day Two, Friday 22nd June.
For more information on the Conference please click here.